(Q57809694)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

title

Comparing the effects of different cell death programs in tumor progression and immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

1 reference

1 reference

Michelle N Messmer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Annelise G Snyder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Andrew Oberst

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

language of work or name

English

0 references

publication date

19 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

29 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

115-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

29 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apoptosis: a review of programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Dying cells actively regulate adaptive immune responses

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Initiation and execution mechanisms of necroptosis: an overview

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Necroptosis in development, inflammation and disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

An outline of necrosome triggers

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Programmed necrosis in inflammation: Toward identification of the effector molecules

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The 'complexities' of life and death: death receptor signalling platforms

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apoptosis: controlled demolition at the cellular level

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Exploitation of Apoptotic Regulation in Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apoptosome structure, assembly, and procaspase activation.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

XIAP discriminates between type I and type II FAS-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Mitochondrial apoptosis: killing cancer using the enemy within.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apaf-1: Regulation and function in cell death

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Death begets a new beginning.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Cell Death, Nucleic acids and Immunity: Inflammation beyond the Grave.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Autoimmunity and the clearance of dead cells

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

More to Life than NF-κB in TNFR1 Signaling

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

RIP3 mediates the embryonic lethality of caspase-8-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Virus inhibition of RIP3-dependent necrosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Caspase-8 as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

1 reference

7 January 2021

The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Plasma membrane changes during programmed cell deaths.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Identification of a dendritic cell receptor that couples sensing of necrosis to immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Activation of P2X(7) receptor by ATP plays an important role in regulating inflammatory responses during acute viral infection

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

RIPK3-driven cell death during virus infections

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Metabolic Regulation of Apoptosis in Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Role of the tumor microenvironment in regulating apoptosis and cancer progression.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Evading apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Deconstructing networks of p53-mediated tumor suppression in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Hypoxia: a key regulator of angiogenesis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A "structure-activity relationship" perspective.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The three Es of cancer immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Defective death receptor signaling as a cause of tumor immune escape

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Prevalence and clinical significance of resistance to perforin- and FAS-mediated cell death in leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

1 reference

7 January 2021

A fate worse than death: apoptosis as an oncogenic process

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Hypoxia-induced cell death in human malignant glioma cells: energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Hypoxia in cancer: significance and impact on clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The in vivo evidence for regulated necrosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Biomarkers for the detection of necroptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Necroptosis, in vivo detection in experimental disease models

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Low Necroptosis Process Predicts Poor Treatment Outcome of Human Papillomavirus Positive Cervical Cancers by Decreasing Tumor-Associated Macrophages M1 Polarization.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apoptosis in the development and treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Molecular Pathways: The Necrosome-A Target for Cancer Therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Shikonin kills glioma cells through necroptosis mediated by RIP-1

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Ionic immune suppression within the tumour microenvironment limits T cell effector function.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Necroptotic cell death in anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Necroptosis in cancer: An angel or a demon?

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Relevance of necroptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Therapeutic exploitation of necroptosis for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Immunogenic death of colon cancer cells treated with oxaliplatin

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Immunogenic Apoptotic Cell Death and Anticancer Immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Caspase inhibitors: a review of recently patented compounds (2013-2015).

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Caspase Inhibition Prevents Tumor Necrosis Factor-α-Induced Apoptosis and Promotes Necrotic Cell Death in Mouse Hepatocytes in Vivo and in Vitro

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Exploitation of necroptosis for treatment of caspase-compromised cancers

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Antitumor activity of HPA3P through RIPK3-dependent regulated necrotic cell death in colon cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Naturally-occurring shikonin analogues--a class of necroptotic inducers that circumvent cancer drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Shikonin circumvents cancer drug resistance by induction of a necroptotic death

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

IAP antagonists induce anti-tumor immunity in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Regression of apoptosis-resistant colorectal tumors by induction of necroptosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Therapeutic vaccination against murine lymphoma by intratumoral injection of recombinant fowlpox virus encoding CD40 ligand

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Expression of p16(INK4A) induces dominant suppression of glioblastoma growth in situ through necrosis and cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Understanding the tumor immune microenvironment (TIME) for effective therapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Mechanisms regulating T-cell infiltration and activity in solid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Tumor-intrinsic oncogene pathways mediating immune avoidance

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Innate and adaptive immune cells in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Classifying Cancers Based on T-cell Infiltration and PD-L1.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

The future of cancer therapy: selecting patients likely to respond to PD1/L1 blockade

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Hallmarks of response to immune checkpoint blockade

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Tumour heterogeneity and resistance to cancer therapies.

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Is autoimmunity the Achilles' heel of cancer immunotherapy?

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Recognizing and managing on toxicities in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41418-018-0214-4

7 January 2021

Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer

1 reference

12 December 2020

Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer

1 reference

12 December 2020

The potential for caspases in drug discovery

1 reference

12 December 2020

The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis

1 reference

12 December 2020

Inflammation-driven carcinogenesis is mediated through STING

1 reference

12 December 2020

Necroptosis: an alternative cell death program defending against cancer.

1 reference

12 December 2020

10.1038/S41418-018-0214-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30341424%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

PubMed publication ID

30341424

1 reference